Since the development of RTKi resistance in our endometrial cancer model was dependent on a resurgence in Akt activity (Figure 2D), we examined whether the re-sensitization of resistant cells following PHLDA1 induction was mediated by a suppression of Akt signaling. The gene discussed is PHLDA1; the disease is endometrial cancer.